Sanjay Mehta. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antihypertensive Agents/adverse effectsAntihypertensive Agents/therapeutic useBosentanEpoprostenol/adverse effectsEpoprostenol/analogs & derivativesEpoprostenol/therapeutic useHumansHypertension, Pulmonary/classificationHypertension, Pulmonary/drug therapyHypertension, Pulmonary/mortalityRandomized Controlled Trials as TopicSulfonamides/therapeutic useTreatment Outcome
Substances: See more » Antihypertensive AgentsSulfonamidesEpoprostenolBosentantreprostinil
Year: 2003 PMID: 14665473 DOI: 10.1378/chest.124.6.2045
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410